I wanted to raise a couple of things because one of our meetings with the officials is on the Canada Health Act and the annual report, so they are focused on that.
It's a good idea within that realm to talk about pharmacare because pharmacare is one of those things that is excluded from the Canada Health Act. It might be a bit much to try to have another briefing on pharmacare on top of that.
The other thing I would raise is with regard to some of the agencies that are involved in the pharmacare question. There's the Canadian Agency for Drugs and Technologies in Health, which provides recommendations on formulary listings; the Patented Medicine Prices Review Board, which is responsible for regulating drug prices; and the Canadian Institute for Health Information.
There's a range of federal organizations outside of the department we would want to hear from probably in a separate meeting from this briefing we're having on the Canada Health Act.
If I were you, I would separate the pharmacare issue out from the meetings that are currently scheduled and I would just have a separate meeting.